PARIS and CHICAGO and NASHVILLE, April 3t,2025 -Therapixel, creators of MammoScreen®, a leadingartificial intelligence (Al) solution for breast cancer screening, today announced a strategic partnership withOnsite Women's Health, one of the nation's largest in-office breast health and imaging networks. Throughthis collaboration, Onsite will offer MlammoScreen across its 1 50+ locations to elevate patient care, whileempowering radiologists with Al-driven insights to support earlier and more accurate cancer detection.
'This partnership marks a significant milestone in our mission to bring life-saving technology to womenacross the United States" said Matthieu Leclerc-Chalvet, CE0 of Therapixel. "By integrating MammoScreeninto their workflow, Onsite Women's Health is leveraging the most comprehensive breast cancer screeningAl available-delivering faster, more accurate readings and ultimately improving patient outcomes across itsnetwork."
'At Onsite, we're constantly evaluating opportunities to elevate the standard of care we deliver" said JillianWright, CE0 of Onsite Women's Health. “We're committed to equipping our radiologists with the besttechnologies available to ensure the highest quality of care for our partner practices and, most importantlyour patients. We believe MlammoScreen will optimize our ability to detect breast cancer as early as possibleand save more lives.
MammoScreen uses deep learning to assist radiologists by identifying subtle abnormalities that may bemissed during manual review. lt has demonstrated the ability to detect 42% of cancers one year prior todiagnosis, and 38.5% two years prior. The technology also reduces reader fatigue and inter-reader variability,improving consistency and equity in patient care. Additionally, by increasing specificity, MammoScreen helpslower unnecessary recalls-minimizing anxiety and inconvenience for patients.
By integrating MammoScreen into its clinical workflow, Onsite radiologists and partner practices will benefitfrom added diagnostic confidence, improved efficiency, and streamlined operations-all to support betteroutcomes for the patients they serve.
"What attracted us most to this partnership was a shared goal: to improve outcomes for women," addedWright. "By bringing together our national footprint with MammoScreen's powerful technology, we'redelivering on our mission to make high-quality breast care more accessible, personalized, and effective.
About Onsite Women's Health
In partnership with forward-thinking providers across the country, Onsite Women's Health offerscomprehensive in-office breast health and imaging services - including 3D screening mammography,automated screening breast ultrasound, diagnostic mammography/breast ultrasound and lifetime breastcancer risk assessment. Onsite is committed to saving more women's lives through earlier cancer detectiorand is materially impacting breast cancer screening compliance and detection rates through offeringconvenient access to mammography, contracting with breast-focused radiologists, and utilizing the mosinnovative equipment and Alpowered technology available on the market. By offering the ability to risk-assess patients using tools powered by Al, Onsite supports the providers' ability to offer personalized andprecise care plans to patients based on individual risk profiles. Onsite services increase patient satisfactiorimprove breast health services and offer an additional revenue opportunity for practice partners. Since itsfounding in 2008, Onsite has performed more than two million exams across 26 states
NEV
About Therapixel
Therapixel is a French company specialized in the design and commercialization of Al-powered medicalimaging software, with the goal of delivering pertinent information at the right time to healthcareprofessionals. Winner of the Digital Mammography DREAM Challenge in 2017, the global competition onbreast cancer detection with Al, Therapixel has developed MammoScreen®, a software that helps with theinterpretation of screening 2D and 3D mammograms. With MammoScreen@, even experienced radiologistscan improve their performance, feel more confident in their judament, and reassure women quicker. Findmore at www.mammoscreen.com
Press Contact:
David Troy
dtroy@therapixel.com
media@therapixel.com
Therapixel
ulie Plummer
jplummer@onsitewomenshealth.comOnsite Women's Health